Quantification of enhancement of renal parenchymal masses with contrast-enhanced ultrasound.

The purpose of this study was to investigate the value of quantitative assessment of enhancement in diagnosing renal cell carcinoma (RCC) with contrast-enhanced ultrasound (CEUS). A total of 73 solid renal parenchymal masses underwent both conventional ultrasound and CEUS. We compared the difference in maximum diameters on conventional ultrasound and CEUS between the benign and malignant groups. Enhancement features derived from a time-intensity curve were also analyzed. The diameters of renal cancer were found to be larger on CEUS than on conventional ultrasound (p < 0.05). When cutoff values of 4.74 s for washout time and 8.52% for enhancement intensity at 60 s for diagnosing RCCs were applied, the sensitivity, specificity and area under the receiver operating characteristic curve were 67.3%, 95.2%, 86.5% and 65.4%, 81.0%, 68.4%, respectively. The sensitivity and specificity for these two enhancement characteristics combined as a criterion for differentiating RCCs from benign lesions were 44.0% and 99.1%, respectively. Early washout in the area of maximal intensity in the interior of the lesion and prolonged washout in the whole area of the lesion are specific CEUS manifestations suggestive of RCC.

[1]  D. Lianfang,et al.  Diagnostic Efficacy of Contrast‐Enhanced Ultrasonography in Solid Renal Parenchymal Lesions With Maximum Diameters of 5 cm , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  Y. Kakehi,et al.  Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases , 2002, International journal of urology : official journal of the Japanese Urological Association.

[3]  H. Wijkstra,et al.  Evaluation of Renal Masses with Contrast-Enhanced Ultrasound , 2013, Current Urology Reports.

[4]  P. Russo,et al.  Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. , 2011, AJR. American journal of roentgenology.

[5]  A. Ignee,et al.  Contrast enhanced ultrasound of renal masses. , 2010, World journal of radiology.

[6]  G M Baxter,et al.  Current and potential renal applications of contrast-enhanced ultrasound. , 2012, Clinical radiology.

[7]  A. Ignee,et al.  The value of contrast enhanced ultrasound (CEUS) in the characterisation of patients with renal masses. , 2010, Clinical hemorheology and microcirculation.

[8]  Hui-Xiong Xu Era of diagnostic and interventional ultrasound. , 2011, World journal of radiology.

[9]  Shigeyuki Aoki,et al.  Contrast‐enhanced ultrasound using a time‐intensity curve for the diagnosis of renal cell carcinoma , 2011, BJU international.

[10]  Michele Bertolotto,et al.  The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology , 2011, World Journal of Urology.

[11]  L Barozzi,et al.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications , 2011, Ultraschall in der Medizin.

[12]  B. K. Park,et al.  Characterization of Renal Cell Carcinoma Using Agent Detection Imaging: Comparison with Gray-Scale US , 2005, Korean journal of radiology.

[13]  P. Livne,et al.  Significance of angiogenesis and microvascular invasion in renal cell carcinoma , 2009, Pathology Oncology Research.